NovoNordisk surges 11% after Wegovy possible medical breakthrough! 📈

Shares of Danish company NovoNordisk (NOVOB.DK) are gaining nearly 11% and climbing to historic highs. The reason is the results of a study of the obesity-fighting drug Wegovy. They indicated that the drug can reduce the risk of heart disease in overweight adults by up to 20%. The market sees chances that the company is in possession of a drug that effectively helps combat chronic obesity and reduces the risk of its complications.

In a double-blind trial, Wegovy (semaglutide) was administered to a group of 17,604 adults with obesity and cardiovascular disease (no history of diabetes, data from more than 800 centers and 41 countries) over the age of 45 for up to five years;
To date, there are no approved weight-reduction drugs that provide effective weight control while reducing the risk of heart attack, stroke or death from cardiovascular causes;
Novo Nordisk will apply for regulatory approval (FDA) and expanded indications for Wegovy 2.4 mg in the US and EU later this year. It will also present the scientific behind-the-scenes of the study and its results at a scientific conference, also scheduled for 2023.

NovoNordisk shares, D1 interval. Shares are climbing at ATH levels above 1200 DK per share. Source: xStation5

14 November 2025, 6:28 PM

Alibaba sell-off extends amid White House national security concerns📌

14 November 2025, 4:42 PM

US Earnings Season Summary 🗽What the Latest FactSet Data Shows

14 November 2025, 4:06 PM

US Open: US100 initiates rebound attempt 🗽Micron shares near ATH📈

14 November 2025, 12:56 PM

Micron Surges on Record DRAM Pricing

stocks

Cookie name	Description
SERVERID
userBranchSymbol	Expiration date 1 day
test_cookie	Expiration date 1 hour
adobe_unique_id	Expiration date 364 days
__hssc	Expiration date 1 hour
SESSID	Expiration date 1 day
__cf_bm	Expiration date 1 hour
intercom-id-iojaybix	Expiration date 270 days
intercom-session-iojaybix	Expiration date 6 days
xtbCookiesSettings	Expiration date 364 days
TS5b68a4e1027
countryIsoCode
xtbLanguageSettings	Expiration date 364 days
userPreviousBranchSymbol	Expiration date 364 days
intercom-device-id-iojaybix	Expiration date 270 days
__cfruid
_cfuvid

Cookie name	Description
_gid	Expiration date 1 day
_gat_UA-98728395-1	Expiration date 1 hour
_gat_UA-121192761-1	Expiration date 1 hour
_gcl_au	Expiration date 89 days
_ga_CBPL72L2EC	Expiration date 729 days
_ga	Expiration date 729 days
__hstc	Expiration date 179 days
__hssrc
_vwo_uuid_v2	Expiration date 365 days
_ga_TC79BEJ20L	Expiration date 729 days
_vwo_uuid	Expiration date 365 days
_vwo_ds	Expiration date 29 days
_vwo_sn	Expiration date 1 hour
_vis_opt_s	Expiration date 99 days
_vis_opt_test_cookie
af_id	Expiration date 394 days
afUserId	Expiration date 730 days
AF_SYNC	Expiration date 6 days
AnalyticsSyncHistory	Expiration date 29 days

Cookie name	Description
MUID	Expiration date 389 days
_omappvp	Expiration date 3998 days
_omappvs	Expiration date 1 hour
_uetsid	Expiration date 1 day
_uetvid	Expiration date 389 days
_fbp	Expiration date 89 days
fr	Expiration date 89 days
_ttp	Expiration date 89 days
_tt_enable_cookie	Expiration date 89 days
hubspotutk	Expiration date 179 days
IDE	Expiration date 389 days
YSC
VISITOR_INFO1_LIVE	Expiration date 179 days
li_sugr	Expiration date 89 days
guest_id_marketing	Expiration date 729 days
guest_id_ads	Expiration date 729 days
guest_id	Expiration date 729 days
muc_ads	Expiration date 729 days
VISITOR_PRIVACY_METADATA	Expiration date 179 days
MSPTC	Expiration date 389 days

Cookie name	Description
bcookie	Expiration date 364 days
lidc	Expiration date 1 day
UserMatchHistory	Expiration date 29 days
bscookie	Expiration date 364 days
li_gc	Expiration date 179 days
personalization_id	Expiration date 729 days

NovoNordisk surges 11% after Wegovy possible medical breakthrough! 📈

Join over 2 000 000 XTB Group Clients from around the world